Israel can grow its cannabis and CBD sector with government blessing

Although cannabis and all its parts are considered in Israel as dangerous drugs, government support for cannabis start-ups and liberal policies with regard to research have helped the country to develop an active cannabis industry.

The domestic Israeli CBD market remains restricted, but the country can contribute to the global CBD sector in other ways, such as research and farming, according to Saul Kaye, CEO of cannabis technology and medical research firm ICann.

Currently, cannabis and its derivatives are only available through prescription. And while the law has allowed doctors to prescribe it for patients, it hasn’t allowed the market to flourish yet across the board. Overall CBD, is still considered to be like THC.

“That will ideally change,” Kaye told CBD-Intel. “We are hoping for new legislation around CBD so it will be regulated completely separately.”

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ Israel can grow its cannabis and CBD sector with government blessing ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Israel can grow its cannabis and CBD sector with government blessing ”






      Although cannabis and all its parts are considered in Israel as dangerous drugs, government support for cannabis start-ups and liberal policies with regard to research have helped the country to develop an active cannabis industry.

      The domestic Israeli CBD market remains restricted, but the country can contribute to the global CBD sector in other ways, such as research and farming, according to Saul Kaye, CEO of cannabis technology and medical research firm ICann.

      Currently, cannabis and its derivatives are only available through prescription. And while the law has allowed doctors to prescribe it for patients, it hasn’t allowed the market to flourish yet across the board. Overall CBD, is still considered to be like THC.

      “That will ideally change,” Kaye told CBD-Intel. “We are hoping for new legislation around CBD so it will be regulated completely separately.”

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik